CVE-2018-16631
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- Required
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
- Record
CVE-2018-16631- CVSS 3.0
- 5.4 Medium
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - CVSS 2.0
- 3.5 Low
AV:N/AC:M/Au:S/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
- Record
CVE-2018-16631- Updated
- 2026-11-02
EUVDEUVD-2018-8436 No score
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
- Record
EUVD-2018-8436- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-m4pp-4rvc-85j4
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
- Record
GHSA-m4pp-4rvc-85j4- CVSS 3.0
- 5.4 Medium
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
OSV
Subrion CMS v4.2.1 allows XSS via the panel/configuration/general/ SITE TITLE parameter.
- Record
CVE-2018-16631- CVSS 3.0
- 5.4 Medium
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2018-16631 is a medium vulnerability (CVSS 5.4) in Intelliants Subrion Cms, published December 4, 2018. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.56%, the 46th percentile. No source names a fixed version.